YJ1234
2021-06-17
Like pls!
Raw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
6
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":161505935,"tweetId":"161505935","gmtCreate":1623932911027,"gmtModify":1634025718480,"author":{"id":3569451715493894,"idStr":"3569451715493894","authorId":3569451715493894,"authorIdStr":"3569451715493894","name":"YJ1234","avatar":"https://static.tigerbbs.com/da7bfb74470f0f05e980715d2cba26f6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":17,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like pls!</p></body></html>","htmlText":"<html><head></head><body><p>Like pls!</p></body></html>","text":"Like pls!","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":6,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/161505935","repostId":1195023201,"repostType":4,"repost":{"id":"1195023201","kind":"news","pubTimestamp":1623930270,"share":"https://www.laohu8.com/m/news/1195023201?lang=&edition=full","pubTime":"2021-06-17 19:44","market":"us","language":"en","title":"Raw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=1195023201","media":"benzinga","summary":"Serum Institute of India (SII) is yet to receive raw materials from the U.S. required to produce the","content":"<ul>\n <li>Serum Institute of India (SII) is yet to receive raw materials from the U.S. required to produce the <b>Novavax Inc</b> vaccine despite diplomatic interventions by India, said an official aware of the development.</li>\n <li>The delay in receiving raw materials such as bioreactor bags and enzymes means that SII's launch of the Novavax vaccine, dubbed Covovax in India, will not likely happen before September, as planned initially.</li>\n <li>The company said raw material shortages have led to the delay in launching the vaccine.</li>\n <li>The U.S. lifted the export ban on raw materials on June 4.</li>\n <li>SII is the manufacturing partner for Novavax in India, where the firm has committed to producing up to 1 billion doses.</li>\n <li>Also, the Serum Institute of India plans to start clinical trials of the Novavax shot for children in July, according to ANI quoting sources.</li>\n <li>Earlier this week, NVAX's COVID-19 vaccine demonstrated 90% efficacy.</li>\n <li><b>Price Action:</b>NVAX shares are up 5.9% at $186.68 during the premarket trading session on the last check Thursday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 19:44 GMT+8 <a href=https://wwww.benzinga.com/general/biotech/21/06/21602943/raw-material-shortage-holding-up-novavaxs-covid-19-shot-manufacturing-says-serum-institute><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Serum Institute of India (SII) is yet to receive raw materials from the U.S. required to produce the Novavax Inc vaccine despite diplomatic interventions by India, said an official aware of the ...</p>\n\n<a href=\"https://wwww.benzinga.com/general/biotech/21/06/21602943/raw-material-shortage-holding-up-novavaxs-covid-19-shot-manufacturing-says-serum-institute\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://wwww.benzinga.com/general/biotech/21/06/21602943/raw-material-shortage-holding-up-novavaxs-covid-19-shot-manufacturing-says-serum-institute","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195023201","content_text":"Serum Institute of India (SII) is yet to receive raw materials from the U.S. required to produce the Novavax Inc vaccine despite diplomatic interventions by India, said an official aware of the development.\nThe delay in receiving raw materials such as bioreactor bags and enzymes means that SII's launch of the Novavax vaccine, dubbed Covovax in India, will not likely happen before September, as planned initially.\nThe company said raw material shortages have led to the delay in launching the vaccine.\nThe U.S. lifted the export ban on raw materials on June 4.\nSII is the manufacturing partner for Novavax in India, where the firm has committed to producing up to 1 billion doses.\nAlso, the Serum Institute of India plans to start clinical trials of the Novavax shot for children in July, according to ANI quoting sources.\nEarlier this week, NVAX's COVID-19 vaccine demonstrated 90% efficacy.\nPrice Action:NVAX shares are up 5.9% at $186.68 during the premarket trading session on the last check Thursday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":101,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/161505935"}
精彩评论